Skip to main content
Terug
SYK logo

Stryker Corporation

Datakwaliteit: 100%
Oversold
SYK
NYSE Healthcare Medical - Devices
€ 327,65
▼ € 0,86 (-0,26%)
Marktkapitalisatie: 125,39B
Dagbereik
€ 324,93 € 334,23
52-Weeksbereik
€ 324,93 € 404,87
Volume
1.934.022
50D / 200D Gem.
€ 363,32 / € 372,67
Vorige Slotkoers
€ 328,51

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (631 peers)

Metriek Aandeel Sector Mediaan
P/E 38,6 0,2
P/B 5,6 3,0
ROE % 15,1 3,6
Net Margin % 12,9 3,8
Rev Growth 5Y % 10,1 9,9
D/E 0,7 0,2

Koersdoel Analisten

Hold
€ 428,67 +30.8%
Low: € 390,00 High: € 469,00
Forward K/W
21,82
Forward WPA
€ 15,01
WPA Groei (sch.)
+0,0%
Omzet Sch.
27,34B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 22,82
€ 22,27 – € 23,20
37,93B 2
FY2029 € 21,03
€ 20,52 – € 21,38
35,09B 4
FY2028 € 18,72
€ 16,95 – € 20,12
32,17B 6

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-01-29 € 4,40 € 4,47 +1,6%
2025-10-30 € 3,13 € 3,19 +1,9%
2025-07-31 € 3,07 € 3,13 +2,0%
2025-05-01 € 2,71 € 2,84 +4,8%
2025-01-28 € 3,87 € 4,01 +3,6%
2024-10-29 € 2,77 € 2,87 +3,6%
2024-07-30 € 2,79 € 2,81 +0,7%
2024-04-30 € 2,35 € 2,50 +6,4%

Insider Trading Activity

18 transactions
Date Insider Type Shares Price Value
Mar 9, 2026
Lobo Kevin
Chair and CEO
grant 50.332
Mar 9, 2026
Menon Viju
Group President
grant 9.320
Mar 9, 2026
Stiles Spencer S
President and COO
grant 14.912
Feb 23, 2026
STRYKER RONDA E
Director
other 55.600
Feb 4, 2026
Fink M Kathryn
VP, Chief HR Officer
grant 5.654
Feb 4, 2026
King Debra
See Remarks
grant 3.992
Feb 4, 2026
Wells Preston Wendell
VP, Chief Financial Officer
grant 11.974
Feb 3, 2026
Stiles Spencer S
President and COO
other 35.372 € 96,64
Nov 21, 2025
Pierce James Andrew
Group President
other 422
Nov 14, 2025
Berry William E Jr
VP, Chief Accounting Officer
other 12.822 € 154,14
Nov 14, 2025
Berry William E Jr
VP, Chief Accounting Officer
sell 1.953 € 365,49 € 713.801,97
Aug 1, 2025
Montagnino Kimberly Ann
VP, Chief Comm. Officer
other 155 € 392,73 € 60.873,15
May 12, 2025
Berry William E Jr
VP, Chief Accounting Officer
sell 1.241 € 388,56 € 482.202,34
May 8, 2025
Caforio Giovanni
Director
grant 560
May 8, 2025
McCoy Sherilyn S
Director
grant 560
May 8, 2025
Suri Rajeev
Director
grant 560
May 8, 2025
Silvernail Andrew K
Director
grant 560
May 8, 2025
BRAINERD MARY K
Director
grant 560

Dividend History

7 yr streak

Yield

0,01%

Payout Ratio

0,40%

Growth (3Y)

6,25%

Growth (5Y)

7,62%

Ex-Date Payment Date Amount Yield
Mar 31, 2026 Apr 30, 2026 € 0,88 1,05%
Dec 31, 2025 Jan 30, 2026 € 0,88 0,97%
Sep 30, 2025 Oct 31, 2025 € 0,84 0,91%
Jun 30, 2025 Jul 31, 2025 € 0,84 0,84%
Mar 31, 2025 Apr 30, 2025 € 0,84 0,88%
Dec 31, 2024 Jan 31, 2025 € 0,84 0,90%
Sep 30, 2024 Oct 31, 2024 € 0,80 0,89%
Jun 28, 2024 Jul 31, 2024 € 0,80 0,93%
Mar 27, 2024 Apr 30, 2024 € 0,80 0,86%
Dec 28, 2023 Jan 31, 2024 € 0,80 1,02%
Sep 28, 2023 Oct 31, 2023 € 0,75 1,10%
Jun 29, 2023 Jul 31, 2023 € 0,75 0,98%
Mar 30, 2023 Apr 28, 2023 € 0,75 1,03%
Dec 29, 2022 Jan 31, 2023 € 0,75 1,15%
Sep 29, 2022 Oct 31, 2022 € 0,70 1,35%
Jun 29, 2022 Jul 29, 2022 € 0,70 1,36%
Mar 30, 2022 Apr 29, 2022 € 0,70 0,98%
Dec 30, 2021 Jan 31, 2022 € 0,70 0,95%
Sep 29, 2021 Oct 29, 2021 € 0,63 0,94%
Jun 29, 2021 Jul 30, 2021 € 0,63 0,95%

Belangrijkste Punten

Revenue grew 10,07% annually over 5 years — strong growth
ROE of 15,08% — decent returns on equity
Generating 4,28B in free cash flow
P/E of 38,63 — premium valuation
Cash machine — converts 131,95% of earnings into free cash flow
Capital efficient — spends only 3,03% of revenue on capex

Groei

Revenue Growth (5Y)
10,07%
Revenue (1Y)11,16%
Earnings (1Y)8,45%
FCF Growth (3Y)16,87%

Kwaliteit

Return on Equity
15,08%
ROIC9,84%
Net Margin12,92%
Op. Margin19,47%

Veiligheid

Debt / Equity
0,66
Current Ratio1,89
Interest Coverage8,05

Waardering

P/E Ratio
38,63
Forward P/E21,82
P/B Ratio5,59
EV/EBITDA27,87
Dividend Yield0,01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11,16% Revenue Growth (3Y) 10,69%
Earnings Growth (1Y) 8,45% Earnings Growth (3Y) 1,27%
Revenue Growth (5Y) 10,07% Earnings Growth (5Y) 12,96%
Profitability
Revenue (TTM) 25,12B Net Income (TTM) 3,25B
ROE 15,08% ROA 6,78%
Gross Margin 63,96% Operating Margin 19,47%
Net Margin 12,92% Free Cash Flow (TTM) 4,28B
ROIC 9,84% FCF Growth (3Y) 16,87%
Safety
Debt / Equity 0,66 Current Ratio 1,89
Interest Coverage 8,05
Dividends
Dividend Yield 0,01% Payout Ratio 0,40%
Dividend Growth (3Y) 6,25% Dividend Growth (5Y) 7,62%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 38,63 Forward P/E 21,82
P/B Ratio 5,59 P/S Ratio 4,99
PEG Ratio 5,16 Forward PEG N/A
EV/EBITDA 27,87 Fwd EV/EBITDA 21,75
Forward P/S 4,59 Fwd Earnings Yield 4,58%
FCF Yield 3,42%
Market Cap 125,39B Enterprise Value 136,24B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 25,12B 22,60B 20,50B 18,45B 17,11B
Net Income 3,25B 2,99B 3,17B 2,36B 1,99B
EPS (Diluted) 8,40 7,76 8,25 6,17 5,22
Gross Profit 16,07B 13,98B 12,49B 11,04B 10,71B
Operating Income 4,89B 5,06B 4,28B 3,73B 3,76B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 47,84B 42,97B 39,91B 36,88B 34,63B
Total Liabilities 25,42B 22,34B 21,32B 20,27B 19,75B
Shareholders' Equity 22,42B 20,63B 18,59B 16,62B 14,88B
Total Debt 14,86B 14,12B 13,49B 13,53B 12,90B
Cash & Equivalents 4,01B 3,65B 2,97B 1,84B 2,94B
Current Assets 14,76B 14,85B 12,52B 10,28B 10,02B
Current Liabilities 7,79B 7,62B 7,92B 6,30B 4,55B

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#437 of 1049
48

Recente Activiteit

Ingestapt Cash Flow Compounder
Mar 24, 2026